Daewon Pharmaceutical Decides Voluntary Recall of Antidiarrheal 'Potagel'... "Precautionary Measure"
Daewon Pharmaceutical has initiated a voluntary recall of the antidiarrheal agent 'Potagel.' This is a preventive measure following the Ministry of Food and Drug Safety's recall order issued on the 22nd for certain Potagel products.
Daewon Pharmaceutical Potagel Suspension.
[Photo by Daewon Pharmaceutical website capture]
Daewon Pharmaceutical stated on the 28th, "Since the 24th, we have been conducting a voluntary recall of some Potagel products as a preventive measure," adding, "The voluntary recall targets products with manufacturing numbers adjacent to those subject to the Ministry of Food and Drug Safety's recall order."
Earlier, the Ministry of Food and Drug Safety ordered a recall on the 22nd due to the detection of microorganisms exceeding the standard limits in Daewon Pharmaceutical's antidiarrheal agent 'Potagel Suspension,' citing quality nonconformity (exceeding microbial limits). The recall targets products with the manufacturing number '23084,' with an expiration date of July 13, 2026. The Ministry requested that retailers, pharmacies, and medical institutions holding the recalled medicines immediately stop sales and return the products to the company.
Potagel Suspension, an antidiarrheal agent in stick pouch form, is an over-the-counter drug used to relieve adult stomach and duodenal pain, acute and chronic diarrhea, and acute diarrhea in children aged 24 months and older.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- Experts Shocked by Record Numbers: "Just the Tip of the Iceberg" — The Identity Behind the 90% Dominating Teens [Chuiyakgukga]⑨
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "Bought for a Special Price, but Cheaper Today"... Online Malls Caught Inflating Discount Rates by Raising Regular Prices
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
A Daewon Pharmaceutical representative said, "We are currently investigating the detailed circumstances surrounding the recall order."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.